The Vascular Endothelial Growth Factor Inhibitor Soluble FLT-1 Ameliorates Atopic Dermatitis in APOC1 Transgenic Mice
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:140 |
|---|---|
| Enthalten in: |
The Journal of investigative dermatology - 140(2020), 2 vom: 01. Feb., Seite 491-494.e4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
van Aanhold, Cleo C L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Apolipoprotein C-I |
|---|
| Anmerkungen: |
Date Completed 14.09.2020 Date Revised 14.09.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jid.2019.07.700 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM300357184 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM300357184 | ||
| 003 | DE-627 | ||
| 005 | 20231225102340.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jid.2019.07.700 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1001.xml |
| 035 | |a (DE-627)NLM300357184 | ||
| 035 | |a (NLM)31425708 | ||
| 035 | |a (PII)S0022-202X(19)32697-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a van Aanhold, Cleo C L |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Vascular Endothelial Growth Factor Inhibitor Soluble FLT-1 Ameliorates Atopic Dermatitis in APOC1 Transgenic Mice |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.09.2020 | ||
| 500 | |a Date Revised 14.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Apolipoprotein C-I |2 NLM | |
| 650 | 7 | |a Vascular Endothelial Growth Factor A |2 NLM | |
| 650 | 7 | |a vascular endothelial growth factor A, mouse |2 NLM | |
| 650 | 7 | |a Flt1 protein, mouse |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 650 | 7 | |a Vascular Endothelial Growth Factor Receptor-1 |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Bus, Pascal |e verfasserin |4 aut | |
| 700 | 1 | |a Zandbergen, Malu |e verfasserin |4 aut | |
| 700 | 1 | |a Bos, Manon |e verfasserin |4 aut | |
| 700 | 1 | |a Berbée, Jimmy F P |e verfasserin |4 aut | |
| 700 | 1 | |a Quint, Koen D |e verfasserin |4 aut | |
| 700 | 1 | |a Bruijn, Jan A |e verfasserin |4 aut | |
| 700 | 1 | |a Baelde, Hans J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of investigative dermatology |d 1945 |g 140(2020), 2 vom: 01. Feb., Seite 491-494.e4 |w (DE-627)NLM000018597 |x 1523-1747 |7 nnns |
| 773 | 1 | 8 | |g volume:140 |g year:2020 |g number:2 |g day:01 |g month:02 |g pages:491-494.e4 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jid.2019.07.700 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 140 |j 2020 |e 2 |b 01 |c 02 |h 491-494.e4 | ||